Q3 FY2026 · ended Sep 30, 2026 · Revenue $2.06B, +3.1% YoY · Filed Nov 4, 2026
Zimmer Biomet Holdings, Inc. (ZBH) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $2.1 billion and net income of $191.6 million. Free cash flow was $484.2 million. As of Sep 30, 2026 it held $399.9 million in cash and investments and $7.5 billion in total debt.
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- ZBH (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Warsaw, IN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1136869
- Former names
- ZIMMER HOLDINGS INC (until Jun 8, 2015)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
- Cadre Holdings, Inc. CDRE
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $2.1B | $2.2B | $2.1B | $2.2B | $2.0B |
| Operating income | $307.6M | $326.1M | $373.2M | $154.5M | $351.3M |
| Net income | $191.6M | $198.3M | $238.1M | $139.3M | $230.9M |
| Diluted EPS | $1.00 | $1.03 | $1.22 | $0.70 | $1.16 |
| Operating cash flow | $560.0M | $447.8M | $359.4M | $517.4M | $418.7M |
| Free cash flow | $484.2M | $393.6M | $323.1M | $442.6M | $363.7M |
| Total assets | $23.5B | $22.8B | $22.7B | $23.1B | $23.5B |
| Total liabilities | $10.8B | $10.2B | $10.0B | $10.4B | $10.7B |
| Stockholders' equity | $12.7B | $12.6B | $12.7B | $12.7B | $12.8B |
| Cash and investments | $399.9M | $410.0M | $424.2M | $591.9M | $1.3B |
| Total debt | $7.5B | $7.5B | $7.5B | $7.8B | $8.1B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 8, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Other events
|
Aug 5, 2026 | Aug 5, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
All 1002 Zimmer Biomet Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.